Rheumatology
Conference Coverage
Rheumatology summit tackles racial disparities in lupus trials
Researchers and patients explore why so few Black individuals sign up for studies and highlight projects that aim to develop better strategies.
From the Journals
New clues arise to consequences of calcium crystal deposition in knee OA
Is calcification a cause or a consequence of knee OA? New research has some findings.
From the Journals
Transcutaneous vagus nerve stimulation on the ear proves ineffective in RA treatment
Experts say that these negative findings do not imply that other vagus nerve stimulation therapies will be unsuccessful.
Feature
Humira biosimilars: Five things to know
The launch of eight adalimumab biosimilars so far in 2023 ended Humira’s 20-year monopoly, but it’s not clear yet if these discounted drugs will...
Latest News
Remote teams offer chance to improve difficult-to-treat PsA
This difficult-to-treat cohort is discussed at ZOOM meetings, ranging from monthly to bimonthly, with two dermatologists, two rheumatologists, one...
Latest News
Keep depression, anxiety screening top of mind in patients with psoriatic disease
"Psoriasis patients are twice as likely to have depression, compared to those without psoriasis, and psoriasis patients are 33% more likely to...
From the Journals
Fibromyalgia linked to higher mortality risk
Fibromyalgia was linked to a 27% greater risk of death from all causes in a systematic review and meta-analysis of eight studies published from...
From the Journals
Antidrug antibody effects compared across RA biologics
The presence of antidrug antibodies was associated with a diminished response to biologic disease-modifying antirheumatic drugs in a prospective...
From the Journals
Lupus flares linked to gut bacteria overgrowth
It’s “likely the case” that the pathobiome – with the gut bacteria Ruminococcus blautia gnavus being an important pathobiont – helps to...
Latest News
For psoriasis, review finds several biosimilars as safe and effective as biologics
“The biosimilars evaluated in this study could be considered alongside originators for biologic-naive patients to improve the accessibility of...
Feature
Does colchicine have a role in treating excess ASCVD risk in patients with chronic inflammatory conditions?
Experts in rheumatology, dermatology, and gastroenterology assess the potential of colchicine 0.5 mg to treat residual risk for atherosclerotic...